Response to treatment in a prospective cohort of patients with large ulcerated lesions suspected to be Buruli Ulcer (Mycobacterium ulcerans Disease)

PLoS Neglected Tropical Diseases

Volumn 4, Issue 7, 2010, Pages

  Kibadi, Kapay ^a,b,c   Boelaert, Marleen ^d   Fraga, Alexandra G ^e   Kayinua, Makanzu ^f,g   Longatto Filho, Adhemar ^e,h   Minuku, Jean Bedel ^g   Mputu Yamba, Jean Baptiste ^c   Muyembe Tamfum, Jean Jacques ^b   Pedrosa, Jorge ^e   Roux, Jean Jacques ⁱ   Meyers, Wayne M ^j   Portaels, Françoise ^d  

^a Programme National de Lutte contre l'Ulcère de Buruli PNLUB   (Democratic Republic Congo)

^b Direction of the institute   (Democratic Republic Congo)

^c UNIVERSITY OF KINSHASA   (Congo)

^d INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^e UNIVERSITY OF MINHO   (Portugal)

^f General Reference Hospital of Nsona Mpangu   (Democratic Republic Congo)

^g Rural Health Zone of Nsona Mpangu ^*  (Democratic Republic Congo)

^h SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

ⁱ Chambery Hospital   (France)

^j ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN; STREPTOMYCIN; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; BURULI ULCER; CHILD; CLINICAL TRIAL; COHORT ANALYSIS; CONGO; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; DRUG RESPONSE; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PROSPECTIVE STUDY; RECURRENT DISEASE; RURAL HEALTH CARE; SCHOOL CHILD; SKIN SURGERY; TREATMENT DURATION; TREATMENT INDICATION; CYTOCHEMISTRY; CYTOLOGY; DEMOCRATIC REPUBLIC CONGO; GENETICS; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; MYCOBACTERIUM ULCERANS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIOLOGICAL TECHNIQUES; BURULI ULCER; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DEMOCRATIC REPUBLIC OF THE CONGO; FEMALE; HISTOCYTOCHEMISTRY; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM ULCERANS; PROSPECTIVE STUDIES; RIFAMPIN; STREPTOMYCIN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77957922758     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000736     Document Type: Article

References (35)

1. World Health Organization (2008) Buruli Ulcer: Progress report, 2004-2008. Weekly Epidemiological Record 83: 145-156.
2. Portaels F, Silva MT, Meyers WM (2009) Buruli ulcer. Clin Dermatol 27: 291-305.
3. Janssens PG, Pattyn SR, Meyers WM, Portaels F (2005) Buruli ulcer: an historical overview with updating to 2005. Bull Séanc Acad R Sci Outre-Mer 51: 165-199.
4. Aguiar J, Steunou C (1997) Les ulcères de Buruli en zone rurale au Bénin: prise en charge de 635 cas. Méd Trop 37: 83-89.
5. World Health Organization (2001) Buruli ulcer. Management of Mycobacterium ulcerans diseases. Buntine J, Crofts K, eds. World Health Organization. WHO/ CDS/CPE/GBUI/2001.3. WHO, Geneva. 72 p.
6. Kibadi K (2005) Mycobacterium ulcerans disease (Buruli ulcer): surgical treatment of 102 cases in the Democratic Republic of Congo. Méd Trop 65: 444-448.
7. Espey DK, Djomand G, Diomande I, Dosso M, Saki MZ, et al. (2002) A pilot study of treatment of Buruli ulcer with rifampin and dapsone. Int J Infect Dis 6: 60-65.
8. Pszolla N, Sarkar MR, Strecker W, Kern P, Kinzl L, et al. (2003) Buruli ulcer: A Systemic Disease. Clin Infect Dis 37: 78-82.
9. Etuaful S, Carbonnelle B, Grosset J, Lucas S, Horsfield C, et al. (2005) Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans. Antimicrob Agents Chemother 49: 3182-3186.
10. World Health Organization (2004) Provisional guidance on the role of specific antibiotics in the management of Mycobacterium ulcerans disease (Buruli ulcer). World Health Organization. WHO/CDS/CPE/GBUI/2004.10. Geneva.
11. Chauty A, Johnson RC (2005) Recommandations de l'OMS pour le traitement de l'Ulcère de Buruli. Bull ALLF17: 40.
12. Chauty A, Ardant MF, Adeye A, Euverte H, Guédénon A, et al. (2007) Promising clinical efficacy of streptomycin-rifampin combination for treatment of Buruli ulcer (Mycobacterium ulcerans disease). Antimicrob Agents Chemother 51: 4029-4035.
13. Nienhuis W, Stienstra Y, Thompson WA, Awuah P, Abass K, et al. (2010) Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial. Lancet 375: 664-672.
14. Debacker M, Aguiar J, Steunou C, Zinsou C, Meyers WM, et al. (2004) Mycobacterium ulcerans disease (Buruli ulcer) in a rural hospital, Southern Benin, 1997-2001. Emerg Infect Dis 10: 1391-1398.
15. Phanzu MD, Bafende AE, Dunda KB, Imposo DB, Kibadi AK, et al. (2006) Mycobacterium ulcerans disease (Buruli ulcer) in a rural hospital in Bas-Congo, Democratic Republic of Congo, 2002-2004. Am J Med Hyg 75: 311-314.
16. Kibadi K, Panda M, Muyembe-Tamfum JJ, Fraga AG, Filho AL, et al. (2006) New foci of Buruli ulcer, Angola and Democratic Republic of Congo. Emerg Infect Dis 14: 1790-1792.
17. Schütte D, Um-Boock A, Mensah-Quainoo E, Itin P, Schmid P, et al. (2007) Development of highly organized lymphoid structures in Buruli ulcer lesions after treatment with rifampin and streptomycin. PloS Negl Trop Dis 1: e2.
18. Meyers WM, Connor DH, McCullough B, Bourland J, Moris R, et al. (1974) Distribution of Mycobacterium ulcerans infection in Zaïre, including the report of new foci. Ann Soc Belge Méd Trop 54: 147-157.
19. Eddyani M, Debacker M, Martin A, Aguiar J, Johnson CR, et al. (2008) Primary culture of Mycobacterium ulcerans from human tissue specimens after storage in semi-solid transport medium. J Clin Microbiol 46: 69-72.
20. World Health Organization. Buruli ulcer (2001) Diagnosis of Mycobacterium ulcerans disease. A manual for health care providers. Portaels F, Johnson P, Meyers WM, eds. World Health Organization. WHO/CDS/CPE/GBUI/4. WHO, Geneva. 92 p.
21. Ross BC, Marino L, Oppedisano F, Edwards R, Robins-Browne RM, et al. (1997) Development of a PCR assay for rapid diagnosis of Mycobacterium ulcerans infection. J Clin Microbiol 35: 1696-1700.
22. Mensah-Quainoo E, Yeboah-Manu D, Asebi C, Patafuor F, Ofori-Adjei D, et al. (2008) Diagnostic of Mycobacterium ulcerans infection (Buruli ulcer) at a treatment centre in Ghana: a retrospective analysis of laboratory results of clinically diagnosed cases. Trop Med Int Health 13: 191-198.
23. Stienstra Y, van der Werf TS, Guarner J, Raghunathan PL, Spotts Whitney EA, et al. (2003) Analysis of an IS2404-based nested PCR for diagnosis of Buruli ulcer disease in regions of Ghana where the disease is endemic. J Clin Microbiol 41: 794-797.
24. Connor DH, Lunn FL (1966) Buruli ulceration, a clinicopathologic study of 38 Ugandans with Mycobacterium ulcerans ulceration. Arch Pathol 81: 183-199.
25. Guarner J, Bartlett J, Whitney EA, Raghunathan PL, Stienstra Y, et al. (2003) Histopathologic features of Mycobacterium ulcerans infection. Emerg Infect Dis 9: 651-656.
26. Hayman J (1993) Out of Africa: observations on the histopathology of Mycobacterium ulcerans infection. J Clin Pathol 46: 5-9.
27. Dodge OG (1964) Mycobacterial skin ulcers in Uganda: histopathologic and experimental aspects. J Pathol Bacteriol 88: 167-174.
28. O'Brien DP, Robson ME, Callan PP, McDonald AH (2009) ''Paradoxical'' immune-mediated reactions to Mycobacterium ulcerans during antibiotic treatment a result of treatment success, not failure. Med J Aust 192: 564-566.
29. Johnson PD (2010) Should antibiotics be given for Buruli ulcer. Lancet 375: 618-619.
30. Chauty A, Pluschke G, Ji B (2009) Preliminary results of a clinical trial of eightweek daily treatment with the combination rifampin-clarithromycin for patients with Buruli ulcer. WHO Annual Meeting on Buruli ulcer, Cotonou, Benin, 31 March-2 April 2009. Abstract book. pp 42-43.
31. Nienhuis W, Stienstra Y, Abass KM, et al. (2009) Patterns of healing and paradoxical reactions during antimicrobial treatment of Buruli ulcer - Data from the Burulico Drug Trial in Ghana. WHO Annual Meeting on Buruli ulcer, Cotonou, Benin, 31 March-2 April 2009. Abstract book. 4950 p.
32. Lagarrigue V, Portaels F, Meyers WM, Aguiar J (2000) L'ulcère de Buruli: Attention aux atteintes osseuses! A propos de 33 cas observés au Bénin. Méd Trop 60: 262-266.
33. Programme National Multisectoriel de Lutte contre le VIH/SIDA (PNMLS), Présidence de la République, République Démocratique du Congo. Rapport national de suivi de la mise en oeuvre de la déclaration d'engagement des Chefs d'Etat et de Gouvernement sur le VIH/SIDA (UNGASS), 2007. Publications du PNMLS, 1ère édition, version du 30 janvier 2008. http//www.pnmls.cd.
34. Johnson RC, Nackers F, Glynn JR, de Biurrun Bakedano E, Zinsou C, et al. (2008) Association of HIV infection and Mycobacterium ulcerans disease in Benin. AIDS 22: 901-902.
35. Kibadi K, Colebunders R, Muyembe-Tamfum JJ, Meyers WM, Portaels F (2010) Buruli ulcer lesions in HIV-positive patient. Emerg infect Dis 16: 738-739.